GSK amends academic contest rules, gives access to tech transfer offices
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline, in response to concerns from the gatekeepers of intellectual property rights held by US and Canadian universities, amended the process for academic researchers to submit entries in the company's Discovery Fast Track competition.